ELREXFIO
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90651029
- Registration number
- 7236993
- Mark type
- Stylized text
- Filed
- 16 Apr 2021
- Published for opposition
- 11 Jan 2022
- Registered
- 05 Dec 2023
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer and blood disorders
Owner
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Oct 2023 — USE AMENDMENT FILED
- 02 Nov 2023 — SOU EXTENSION 4 GRANTED
- 23 Oct 2023 — SOU EXTENSION 4 FILED
- 30 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 23 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 23 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 29 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jul 2023 — SOU EXTENSION 3 GRANTED
- 27 Jul 2023 — SOU EXTENSION 3 FILED